BMP8A and metabolic dysfunction-associated steatohepatitis: Another relevant finding to point out in the present study is that serum BMP8A levels are significantly associated with the hepatic fibrosis stage of the NASH patients studied, indicating that circulating BMP8A may be a useful biomarker to distinguish advanced hepatic fibrosis from mild fibrosis.